Developing models of cholangiocarcinoma to close the translational gap in cancer research

Taylor and Francis Group, Expert Opinion on Investigational Drugs, 4(30), p. 439-450, 2021

Journal article published in 2021 by Scott H. Waddell

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by